| 5-R01-EB031022-04 |
Development of a web-based predictive model of nanoparticle delivery to tumors by integrating physiologically-based pharmacokinetic modeling with artificial intelligence |
Zhoumeng Lin |
University of Florida |
| 5-R03-EB032579-02 |
Development of Sulfonium- and Phosphonium-based Cationic Lipid Materials for mRNA Delivery |
Yamin Li |
Upstate Medical University |
| 5-R21-EB033687-02 |
Engineered immunotherapies neutralizing interleukin-22 binding protein |
Joel Collier |
Duke University |
| 5-R01-EB032791-02 |
Engineering of Polymeric Particles for Fetal Therapy |
W. Saltzman |
Yale University |
| 5-R21-EB029572-02 |
Enzyme-Powered Self-Propelled DNA Nanoparticles for Disruption and Antibiotic Delivery in Topical Biofilms |
Jeffrey Moran |
George Mason University |
| 5-R01-EB029455-04 |
Immunoengineered nanotechnology for targeted expansion of regulatory T cells |
Jamie Spangler |
Johns Hopkins University |
| 5-R01-EB034086-03 |
Ionic Liquid-Coated NIR-II Polymer Conjugates as Targeted Brain Theranostics |
Davita Watkins |
Ohio State University |
| 1-R01-EB035146-01A1 |
Modular Toolbox of Protein and Lipid Hybrid Biomaterials for siRNA Delivery |
Jin Montclare |
New York University |
| 5-R21-EB034942-02 |
Optimization of Tannic Acid Lipid Nanoparticles for a Therapeutic mRNA Vaccine Against Melanoma |
Owen Fenton |
Univ of North Carolina Chapel Hill |
| 5-R21-EB033183-02 |
Photoelectroporation: Biomacromolecule delivery via nanoscale light-amplified voltage generators |
Julie Champion |
Georgia Institute of Technology |
